Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0LP3P
|
|||
Drug Name |
PMID30185082-Compound-55
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
THE UNIVERSITY OF MISSISSIPPI THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY
|
|||
Structure |
Download2D MOL |
|||
Formula |
C23H26FN3O3
|
|||
Canonical SMILES |
CC(=O)C1=CC2=C(C=C1)N(C(=O)O2)CCCCN3CCN(CC3)C4=CC=C(C=C4)F
|
|||
InChI |
1S/C23H26FN3O3/c1-17(28)18-4-9-21-22(16-18)30-23(29)27(21)11-3-2-10-25-12-14-26(15-13-25)20-7-5-19(24)6-8-20/h4-9,16H,2-3,10-15H2,1H3
|
|||
InChIKey |
VGDFDVKDWFJQHD-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sigma intracellular receptor 2 (TMEM97) | Target Info | Ligand | [1] |
Target's Patent Info | Sigma intracellular receptor 2 (TMEM97) | Target's Patent Info | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | The sigma-2 (-2) receptor: a review of recent patent applications: 2013-2018.Expert Opin Ther Pat. 2018 Sep;28(9):655-663. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.